Brisbane (Australia) 23 December 2020: Factor Therapeutics Limited (ASX:FTT) (“Company” provides an update on timing regarding the potential transaction with USA-based BrainBiosciences Inc., doing business as LONGMILE Veterinary PET Imaging (“LONGMILE”, to acquire products and technologies for companion animal and equine veterinary imaging.
The Company advises that ASX has provided notice that a decision on the Company’s application for in-principle advice is anticipated to be received early in 2021. By mutual agreement the exclusivity agreement in place between the parties is extended to accommodate the current status.
ends..
Looks like ye olde ASX still not happy, so holds us to ransom... Merry Xmas Mr ASX.
See you all next year, has been a trying 6 months and will be a lean Christmas, so lets hope its all worth the wait.
Seasonal greetings.
TCG
- Forums
- ASX - By Stock
- DLM
- Ann: Market update - commercial transaction
Ann: Market update - commercial transaction, page-2
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O’Donovan, Executive Director
Gerard O’Donovan
Executive Director
SPONSORED BY The Market Online